Patients must have resolved any serious infectious complications related to induction* NOTE: Patients with an HLA-matched donor and proceeding to transplant will be allowed up to one cycle of consolidation treatment
Any significant medical complications related to induction must have resolved
Patients must have resolved any serious infectious complications related to consolidation cycle 2
Any significant medical complications related to consolidation cycle 2 must have resolved
Patients must have resolved any serious infectious complications related to induction
Any significant medical complications related to induction must have resolved
Patients must have resolved any serious infectious complications related to therapy
Any significant medical complications related to therapy must have resolved
CRITERIA FOR MAINTENANCE THERAPY-STEP 4: Patients must have resolved any serious infectious complications related to therapy
CRITERIA FOR MAINTENANCE THERAPY-STEP 4: Any significant medical complications related to therapy must have resolved
All non-hematologic treatment related toxicities that are deemed clinically significant by the treating investigator must have resolved to =< grade 2
Registration Step 3  Maintenance: All non-hematologic treatment related toxicities that are deemed clinically significant by the treating investigator must have resolved to =< grade 2
All acute, clinically significant treatment-related toxicity from prior therapy, except for alopecia, must have resolved to grade =< 1 prior to study entry
All acute, clinically significant treatment-related toxicity from prior therapy, except for alopecia, must have resolved to grade =< 1
